U.S. Markets closed

BIO-key International, Inc. (BKYI)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
4.2100-0.1000 (-2.32%)
At close: 4:00PM EST

4.1500 -0.06 (-1.43%)
After hours: 4:02PM EST

Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close4.3100
Open4.2900
Bid4.1000 x 1200
Ask4.2400 x 2200
Day's Range4.0200 - 4.3800
52 Week Range2.7500 - 20.6400
Volume447,838
Avg. Volume751,550
Market Cap32.785M
Beta (5Y Monthly)1.03
PE Ratio (TTM)N/A
EPS (TTM)-2.2930
Earnings DateNov 12, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    BIO-key Partners with Managed Security Service Provider NGEN to Deliver PortalGuard® Identity-as-a-Service (IDaaS) Cloud Solution to Commercial and Government Customers

    WALL, N.J. and LANHAM, Md., Jan. 19, 2021 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of identity and access management (IAM) solutions powered by biometrics, today announced a new partnership with NGEN LLC, a managed service provider based in Lanham, MD, who has been consistently recognized by CRN Magazine as among the fastest growing IT Service Providers in North America. The partnership has already generated a new customer for BIO-key's PortalGuard® Identity-as-a-Service (IDaaS) platform through the Maryland Education Enterprise Consortium (MEEC) contract vehicle. NGEN's higher education customer supports 14,000+ users and seeks to secure the online user experience across the institution by implementing advanced IAM practices, such as multi-factor authentication, which can be difficult for many smaller enterprise security teams to develop and deploy on their own. In addition to strengthening authentication capabilities, the IT team wanted to offer an improved online student experience with Single Sign-On to critical applications. "Identity Management is a strategic project for our customer this year," said Terry Speigner, President & CEO at NGEN. "At many higher education institutions, it becomes more challenging to maintain a strong IAM program as the complexity of the organization grows, especially when an organization adds more cloud-based applications. PortalGuard IDaaS is a flexible IAM solution that puts you back in control and allows our customers to easily deploy robust enterprise security with scalability and redundancy built-in to improve their overall security posture." "NGEN is the latest success in building out our Channel Alliance Partner Program (CAPP). They are an impressive organization and hit the ground running," said Mark Cochran, President of BIO-key - PortalGuard. "We are actively onboarding new technology, reseller, and managed service partners across North America and abroad to CAPP, based on the growing need for cloud-hosted IAM solutions, and we expect accelerated growth in the program this year. Engaging with channel partners allows us to leverage our respective strengths and to increase our engagement opportunities with a broader base of end customers." About NGEN LLC. (www.ngen.com)NGEN offers a full range of mission critical information technology services and has strategic partnerships with some of the industry’s leading technology manufacturers and developers. As one of the most respected professional organizations in the DC region, NGEN continues to earn the unparalleled trust of its clients as evidenced by our recurring client referrals. NGEN’s success is rooted in an unwavering commitment to delivering quality services and ensuring the highest level of integrity in business. This commitment characterizes our approach to customer engagement and every solution we provide. About BIO-key International, Inc. (www.bio-key.com)BIO-key is revolutionizing authentication with biometric centric, multi-factor identity and access management (IAM) solutions, including its PortalGuard IAM solution, that provide convenient and secure access to devices, information, applications, and high-value transactions. BIO-key's proprietary software and hardware solutions, with industry-leading biometric capabilities, enable large-scale on-premise and Identity-as-a-Service (IDaaS) solutions, including customized enterprise and cloud solutions. BIO-key Safe Harbor Statement All statements contained in this press release other than statements of historical facts are "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes," and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe harbor" provisions of the Act. These statements are not guarantees of future performance or events and are subject to risks and uncertainties that may cause actual results to differ materially from those included within or implied by such forward-looking statements, as well as other factors set forth under the caption see "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2019, and other filings with the Securities and Exchange Commission. Engage with BIO-keyFacebook – Corporate: https://www.facebook.com/BIOkeyInternational/LinkedIn – Corporate: https://www.linkedin.com/company/bio-key-internationalTwitter – Corporate: @BIOkeyIntlTwitter – Investors: @BIO_keyIRStockTwits: BIO_keyIR Investor & Media ContactsWilliam Jones & David CollinsCatalyst IR 212-924-9800bkyi@catalyst-ir.com

  • BIO-key Sees Significant Increase in Customer Demand for its Cloud-Based Authentication Identity-as-a-Service (IDaaS) Solution PortalGuard®
    GlobeNewswire

    BIO-key Sees Significant Increase in Customer Demand for its Cloud-Based Authentication Identity-as-a-Service (IDaaS) Solution PortalGuard®

    WALL, N.J., Jan. 12, 2021 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of identity and access management (IAM) solutions powered by biometrics, today announced that many of its existing customers are migrating from their current on-premises deployment to BIO-key's PortalGuard® Identity-as-a-Service (IDaaS) cloud-based authentication solution. While also onboarding new named customers BIO-key is assisting an increasing base of customers who desire to move more of their critical applications to the cloud and are attracted to improved security and simplified management capabilities of PortalGuard® IDaaS. In Q4 2020, BIO-key migrated nine of its [on-premises] customers to PortalGuard IDaaS, supporting approximately 115,000 users. Also, there is further upside potential of converting over 200 existing on-premises customers representing millions of users to IDaaS in 2021 and beyond. The need to secure data while conforming to increasing security standards and distributed workforces has become a driving force behind customers' move to IDaaS. BIO-key's PortalGuard IDaaS accelerates the transition to a cloud-based identity management solution by providing an enterprise-grade security platform with a strong return on investment. Allowing users self-service access to critical portals, for example, is just one of the ways an IDaaS system can provide support and ROI for businesses. PortalGuard effectively reduces the complexity and cost of its customer's IT infrastructure, making IAM capabilities easier to use and manage. PortalGuard enables identity management via a single "pane of glass" from a security perspective, giving organizations clear visibility to view individual access across the enterprise."The maturation of the cloud services market has enabled IDaaS to emerge as the preferred deployment model versus the traditional on-premises IAM solution," said Mark Cochran, President of BIO-key - PortalGuard. "Enhanced security and scalability, reduction in cost and complexity, along with the relatively easy deployment of IDaaS, makes it an increasingly desirable option for our customers."About BIO-key International, Inc. (www.bio-key.com) BIO-key is revolutionizing authentication with biometric centric, multi-factor identity and access management (IAM) solutions, including its PortalGuard IAM solution, that provide convenient and secure access to devices, information, applications, and high-value transactions. BIO-key's proprietary software and hardware solutions, with industry-leading biometric capabilities, enable large-scale on-premise and Identity-as-a-Service (IDaaS) solutions, including customized enterprise and cloud solutions.BIO-key Safe Harbor Statement All statements contained in this press release other than statements of historical facts are "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes," and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe harbor" provisions of the Act. These statements are not guarantees of future performance or events and are subject to risks and uncertainties that may cause actual results to differ materially from those included within or implied by such forward-looking statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue; our ability to raise additional capital; our ability to protect our intellectual property; changes in business conditions; changes in our sales strategy and product development plans; changes in the marketplace; continued services of our executive management team; security breaches; competition in the biometric technology industry; market acceptance of biometric products generally and our products under development; our ability to execute and deliver on contracts in Africa; our ability to expand into Asia, Africa and other foreign markets; the duration and severity of the current coronavirus COVID-19 pandemic and its effect on our business operations, sales cycles, 3 personnel, and the geographic markets in which we operate; delays in the development of products and statements of assumption underlying any of the foregoing as well as other factors set forth under the caption see "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2019 and other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. Except as required by law, the Company undertakes no obligation to disclose any revision to these forward-looking statements whether as a result of new information, future events, or otherwise. Additionally, there may be other factors of which the Company is not currently aware that may affect matters discussed in forward-looking statements and may also cause actual results to differ materially from those discussed. In particular, the consequences of the coronavirus outbreak to economic conditions and the industry in general and the financial position and operating results of our Company, in particular, have been material, are changing rapidly, and cannot be predicted.Engage with BIO-key Facebook – Corporate: https://www.facebook.com/BIOkeyInternational/ LinkedIn – Corporate: https://www.linkedin.com/company/bio-key-international Twitter – Corporate: @BIOkeyIntl Twitter – Investors: @BIO_keyIR StockTwits: BIO_keyIRInvestor & Media Contacts William Jones & David Collins Catalyst IR 212-924-9800 bkyi@catalyst-ir.com

  • US Department of Justice Division Leverages BIO-key's PortalGuard Solution for Secure Authentication
    GlobeNewswire

    US Department of Justice Division Leverages BIO-key's PortalGuard Solution for Secure Authentication

    WALL, N.J., Jan. 06, 2021 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of identity and access management (IAM) solutions powered by biometrics, today announced that a US Department of Justice division is using BIO-key's PortalGuard IAM solution for secure authentication and access to systems. BIO-key’s PortalGuard IAM solution provides strong multi-factor authentication while reducing user frustration and help desk related costs for customers. PortalGuard meets or exceeds the strictest authentication requirements and facilitates IT resource cost reduction goals."Our team is extremely proud to support this vital national security program," said Mark Cochran, President of BIO-key - PortalGuard. "The BIO-key team has extensive experience supporting many of our national security and law enforcement agency customers which secure the nation from the many threats they face, both foreign and domestic. PortalGuard enables these government agencies to meet the challenges of an evolving threat landscape while securing their operations in a cost-effective manner."About BIO-key International, Inc. (www.bio-key.com) BIO-key is revolutionizing authentication with biometric centric, multi-factor identity and access management (IAM) solutions, including its PortalGuard IAM solution, that provide convenient and secure access to devices, information, applications, and high-value transactions. BIO-key's proprietary software and hardware solutions, with industry-leading biometric capabilities, enable large-scale on-premise and Identity-as-a-Service (IDaaS) solutions, including customized enterprise and cloud solutions.BIO-key Safe Harbor Statement All statements contained in this press release other than statements of historical facts are "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes," and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe harbor" provisions of the Act. These statements are not guarantees of future performance or events and are subject to risks and uncertainties that may cause actual results to differ materially from those included within or implied by such forward-looking statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue; our ability to raise additional capital; our ability to protect our intellectual property; changes in business conditions; changes in our sales strategy and product development plans; changes in the marketplace; continued services of our executive management team; security breaches; competition in the biometric technology industry; market acceptance of biometric products generally and our products under development; our ability to execute and deliver on contracts in Africa; our ability to expand into Asia, Africa and other foreign markets; the duration and severity of the current coronavirus COVID-19 pandemic and its effect on our business operations, sales cycles, 3 personnel, and the geographic markets in which we operate; delays in the development of products and statements of assumption underlying any of the foregoing as well as other factors set forth under the caption see "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2019 and other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. Except as required by law, the Company undertakes no obligation to disclose any revision to these forward-looking statements whether as a result of new information, future events, or otherwise. Additionally, there may be other factors of which the Company is not currently aware that may affect matters discussed in forward-looking statements and may also cause actual results to differ materially from those discussed. In particular, the consequences of the coronavirus outbreak to economic conditions and the industry in general and the financial position and operating results of our Company, in particular, have been material, are changing rapidly, and cannot be predicted.Engage with BIO-key Facebook – Corporate: https://www.facebook.com/BIOkeyInternational/ LinkedIn – Corporate: https://www.linkedin.com/company/bio-key-international Twitter – Corporate: @BIOkeyIntl Twitter – Investors: @BIO_keyIR StockTwits: BIO_keyIRInvestor & Media Contacts William Jones & David Collins Catalyst IR, 212-924-9800 bkyi@catalyst-ir.com